Sign in

    Kenneth Cawkell

    CEO and Chairman at Alpha Cognition Inc
    Board
    Since March 18, 2021
    Age
    73 years
    Education
    Holds a LLB degree.
    Tenure
    Joined ACOG on 03-18-2021 as Corporate Secretary and co-founder, and served as CEO through its qualifying transaction in April 2021.

    Also at Alpha Cognition Inc

    MM
    Michael McFadden
    Chief Executive Officer
    HD
    Henry Du
    Vice President of Finance and Accounting
    LD
    Lauren DAngelo
    Chief Operating Officer (COO)

    About

    Kenneth Cawkell is a seasoned professional with over 30 years of combined experience in legal practice and the biotech industry, having served as managing partner of Cawkell Brodie LLP and founded Neurodyn Life Sciences Inc..

    He joined Alpha Cognition (ACOG) on 03-18-2021 as Corporate Secretary and co-founder, playing a critical role in developing the company’s de-risked drug development strategy and serving as CEO through its qualifying transaction in April 2021.

    Beyond his work at ACOG, his diverse career also spans roles in the legal and entrepreneurial arenas, demonstrating an extensive background in strategic development and leadership that has contributed to his standing in multiple sectors.

    $ACOG Performance Under Kenneth Cawkell

    Past Roles

    OrganizationRoleDate RangeDetails
    Cawkell Brodie LLP Co-founder & Managing Partner 1987 - 2022 Vancouver-based law firm; retired from practice
    Alpha Cognition Inc. Chief Executive Officer Until April 2021 Served through the qualifying transaction before transitioning to current roles

    External Roles

    OrganizationRoleDate RangeDetails
    Neurodyn Life Sciences Inc. Co-founder & CEO Current Private biotech company focused on natural-based products to treat Alzheimer's and other neurodegenerative diseases
    Westmount Minerals Corp. Director Current N/A [N/A]
    Portofino Resources Inc. Director Current N/A [N/A]
    Centurion Minerals Inc. Director Current N/A
    Well Health Technologies Corp. Director Current N/A

    Fixed Compensation

    Data from  FY 2025
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary $40,000 N/A Annual base salary
    Stock Option Compensation $95,000 N/A Granted in stock options
    One-Time Stock Option Grant $100,000 N/A Special catch-up bonus for foregone compensation for long-standing non-employee directors
    Compensation Committee Fee $6,000 N/A Fee for membership on the Compensation Committee
    Governance Committee Fee $5,000 N/A Fee for membership on the Governance Committee

    Performance Compensation

    Data from  FY 2025

    No information available on performance compensation for 2025